Aberrant DNA methylation of APAF1 gene (range, 1% - 18%) in MDS and control groups was 42.6% (n= 23/54) and 0% (n=0/20), respectively, showing the difference was significant (P<0.05). This evidence concerns the gene APAF1 and myelodysplastic syndrome.